org placeholder image

Matthew Calapatia

Associate Scientist at Sigilon Therapeutics

  • LinkedIn

Email Email: m****@sigilon.com

phone noPhone Number: (***)-***-****

map
SIGILON THERAPEUTICS

SIGILON THERAPEUTICS

  • description Description
    Sigilon Therapeutics', a wholly owned subsidiary of Eli Lilly and Company, mission is to create immune-protected, engineered human cells that restore normal physiology in a wide range of dise...

    Read More

  • Employees count Employees 51-200
  • Revenue Revenue 50 Million to 100 Million
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Sigilon Therapeutics Org Chart and Mapping

Employees

Christopher Sparages

Associate Director, Process Development

Kristen Gray

Associate Scienstist, Diabetes Research

Jiang Wu

VP, Head of Bioanalytical, Biomarker and Cmc Analytical Development

Olivia Kelly

Vice President, Islet Cell Therapy Research

Frequently Asked Questions Regarding Matthew Calapatia

Answer: Matthew Calapatia works for Sigilon Therapeutics as Associate Scientist

Answer: Matthew Calapatia’s role in Sigilon Therapeutics is Associate Scientist

Answer: Matthew Calapatia's email address is m***@gmail.com

Answer: Matthew Calapatia's business email address is m****@sigilon.com

Answer: Matthew Calapatia’s direct phone number is (***)-***-****

Answer: Matthew Calapatia works in the industry of: Biotechnology

Answer: Matthew Calapatia works Sigilon Therapeutics located at 100 Binney St, Cambridge, Massachusetts, 02142, United States

Answer: Sigilon Therapeutics's Associate Scientist is Matthew Calapatia

Answer: Matthew Calapatia contact details:

  • Phone number  :  (***)-***-****
  • Email  :  m****@sigilon.com

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access